TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients | stella

Learn About Find trials matched to me

About Learn Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients | stella

Back to Uterine Fibroids (Leiomyoma) trials

Recruiting

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

China

The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang

Key details

Sponsor

Zhejiang University

Collaborators

Jinhua Central Hospital, Huzhou Central Hospital

Enrollment target

~780 participants

Started

January 2026

Primary completion

October 2027

Age range

18 Years – 65 Years

Sex

Female only

View full record on ClinicalTrials.gov

Last updated on clinicaltrials.gov in March 2026.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Diansan Su, PhD

Zhejiang University

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Enrollment status is pulled from ClinicalTrials.gov and may not reflect real-time availability. If a trial appears full when you reach out, the team will let you know.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.